3 C
March 2, 2024
Science and Medical

FDA warns on rare liver injury with leading HCV meds – Seeking Alpha

The FDA has issued a warning about rare cases of liver injury in HCV patients receiving either AbbVie’s (ABBV+0.4%) Mavyret (glecaprevir/pibrentasvir), Merck’s (MRK+0.9%) Zepatier (elbasvir/grazoprevir) or Gilead Sciences’ (GILD+0.6%) Vosevi (sofosbuvir/velpa…
Read More

Related posts

Blizzard conditions to cause travel problems – KCCI Des Moines


CDC sends warning to hunters after deer with tuberculosis found to transmit bacteria to people – FOX 5 DC


Closed-loop artificial pancreas from Tandem, Dexcom aces type 1 diabetes study – FierceBiotech


Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Policy